Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects.

Autor: Alidadi M; Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Barzgar H; Department of Anatomical Sciences, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran., Zaman M; Department of Genetics, Islamic Azad University Tehran Medical Branch, Tehran, Iran., Paevskaya OA; Department of Infectious Diseases, Institute of Public Health named after F.F. Erisman, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia., Metanat Y; Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Sistan and Baluchestan, Iran., Khodabandehloo E; Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran., Moradi V; Hematology and blood transfusion science department, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2024 Nov 18; Vol. 12, pp. 1491282. Date of Electronic Publication: 2024 Nov 18 (Print Publication: 2024).